Initiation of Levodopa Therapy in Parkinsonisn Patients Should be Delayed Until the Advanced Stages of the Disease
Arch Neurol 43:402-407, Melamen,E., 1986
Modification of Parkinson's Disease by Long-Term Levodopa Treatment
Arch Neurol 43:405-407, Markham,C.H.&Diamond,S.G., 1986
Pharmacologic Treatment of Parkinsonian Tremor
Arch Neurol 43:126-127, Koller,W.C., 1986
Painful Parkinson's Disease
Lancet 1:1366-1369, Quinn,N.P.,et al, 1986
Lithium for Painful Dystonia in Parkinson's Disease
Lancet 1:1377, Quinn,N.&Marsden,C.D., 1986
Low-Dose Bromocriptine Therapy in Parkinson's Disease:Double-Blind, Placebo-Controlled Study
Neurol 36:291-293, Staal-Schreinemachers,A.L.,et al, 1986
Parkinson's Disease in Patients with Alzheimer's Disease
Arch Neurol 43:662-664, Leverenz,J.&Sumi,S.M., 1986
On Heredity, Twins, & Parkinson's Disease
Ann Neurol 19:409-411, Duvoisin,R.C., 1986
Parkinson's Disease in Monozygotic Twins
Ann Neurol 19:405-408, Jankovic,J.&Reches,A., 1986
Monozygotic Twins with Parkinson's Disease
Ann Neurol 19:402-405, Koller,W.,et al, 1986
Vascular Parkinsonism & Periarteritis Nodosa
Neurol 36:874-875, Mayo,J.,et al, 1986
Autonomic Dysfunction in Parkinson's Disease
Neurol 36:73-75, Goetz,C.G.,et al, 1986
Lisuride Infusion Pump:A Device for the Treatment of Motor Fluctuations in Parkinson's Disease
Lancet 1:467-470, Obeso,J.A.,et al, 1986
Swallowing & Speech Production in Parkinson's Disease
Ann Neurol 19:238-287, Robbins,J.,et al, 1986
Dopamine D2 Receptor Density Remains Constant in Treated Parkinson's Disease
Ann Neurol 19:487-492, Guttman,M.,et al, 1986
Fetal Neuronal Grafts in Monkeys Given Methylphenyltetrahydropyridine
Lancet 1:1125-1127, Redmond,D.E.,et al, 1986
Paraquat & Parkinson's Disease
Neurol 36:1147, Koller,W.C., 1986
The Neuroleptic Malignant Syndrome:Agent and Host Interaction
Acta Psychiatr Scand 73:337-347, Shaley,A.&Munitz,H., 1986
Parkinsonism Following Dystonia in Three Patients
Movement Disorders 1:151-157, Katchen,M.&Duvoisin,R.C., 1986
Dystonia-Parkinson Syndrome:Differential Effects of Levodopa and Dopamine Agonists
Clin Neuropharmacol 9:298-302, Klawans,H.L.&Paleologos,N., 1986
Dystonia in Untreated Parkinsonism
Clin Neuropharmacol 9:293-297, LeWitt,P.A.,et al, 1986
Atypical Presentation of Progressive Supranuclear Palsy
Ann Neurol 17:334-343, Davis,P.H.,et al, 1985
Treatment of Progressive Supranuclear Palsy with Tricyclic Antidepressants
Neurol 35:1189-1193, Newman,G.C., 1985
The Clinical Syndrome of Striatal Dopamine Deficiency, Parkinsonism Induced by MPTP
NEJM 312:1418-1421, Burns,R.S.,et al, 1985
Permanent Human Parkinsonism Due to 1-Methyl-4-Phenyl-1, 2, 3, 6-Tetrahydropyridine (MPTP) :Seven Cases
Neurol 35:949-956, Ballard,P.A.,et al, 1985
Prediction of Chronic Vegetative State in Children Using Evoked Potentials
Neurol 35:931-934, Frank,L.M.,et al, 1985
Development of Malignant Melanoma after Levodopa Therapy for Parkinson's Disease, Report of Case & Review
Am J Med 79:119-121, Kochar,A.S., 1985
Levodopa & Melanoma:Three Cases & Review of Literature
JNNP 48:585-588, Rampen,F.H.J., 1985
Low-Dose Bromocriptine Therapy in Parkinson's Disease
Arch Neurol 42:586-588, Pfeiffer,R.F.,et al, 1985
Reappraisal of Temporary Levodopa Withdrawal ("Drug Holiday") in Parkinson's Disease
NEJM 313:724-728, Mayeux,R.,et al, 1985
"Drug Holiday"in the Treatment of Parkinson's Disease, A Brief Review
Arch Int Med 145:913-915, Friedman,J.H., 1985
Mesulergin (CU32-085) in the Treatment of Parkinson's Disease
Ann Neurol 17:334-336, Pfeiffer,R.F.,et al, 1985
Reversal of Sleep Disturbance in Parkinson's Disease by Antiparkinsonian Therapy:A Preliminary Study
Neurol 35:527-532, Askenasy,J.J.M.,et al, 1985
The Heterogeneity of Parkinson's Disease:Clinical & Prognostic Implications
Neurol 35:522-526, Zetusky,W.J.,et al, 1985
Association Between Essential Tremor & Parkinson's Disease
Ann Neurol 17:329-333, Gereghty,J.J.,et al, 1985
Low Cancer Rates Among Patients with Parkinson's Disease
Ann Neurol 17:505-509, Jansson,B.,et al, 1985
Radial Compression Neuropathy in Advanced Parkinson's Disease
Arch Neurol 42:695-696, Preston,D.N.,et al, 1985
Severe Compression Neuropathy Following Sudden Onset of Parkinsonian Immobility
Arch Neurol 42:720, Kurlan,R.,et al, 1985
Reversible Parkinsonism Related to Meperidine
NEJM 312:509, Lieberman,A.N.,et al, 1985
The Nucleus Basalis of Meynert in Neurological Disease:A Quantitative Morphological Study
Ann Neurol 17:163-170, Rogers,J.D.,et al, 1985
Acute Exacerbation of Parkinson's Disease with Sulindac
Ann Neurol 17:104-105, Sandyk,R.,et al, 1985
"Apraxia"of Eyelid Opening:An Involuntary Levator Inhibition
Neurol 35:423-427, Lepore,F.E.,et al, 1985
Low Dosages of Bromocriptine Added to Levodopa in Parkinson's Disease
Neurol 35:199-206, Maier,M.M.,et al, 1985
Long-Term Study of Pergolide in Parkinson's Disease
Neurol 35:296-299, Jankovic,J., 1985
Placebo-Controlled Study of Mesulergine in Parkinson's Disease
Neurol 35:161-165, Jankovic,J.,et al, 1985
Late-Onset Hallervorden-Spatz Disease Presenting as Familial Parkinsonism
Neurol 35:227-234, Jankovic,J.,et al, 1985
Persistent Vegetative State, Review & Report of Electrodiagnostic Studies in Eight Cases
Arch Neurol 42:1048-1052, Hansotia,P.L., 1985
Persistent Vegetative State, Extension of the Syndrome to Include Chronic Disorders
Arch Neurol 42:1045-1047, Walshe,T.M.&Leonard,C., 1985
Extrapyramidal Reactions with Metoclopramide
BMJ 291:930-932, Bateman,D.N.,et al, 1985
Cyanide-Induced Parkinsonism:A Clinicopathologic Report
Neurol 35:921-925, Uitti,R.J.,et al, 1985